Bhattacharyya et al., Biochem Pharmacol 2001
(Hyperglycemia) :
Chlorpromazine (CPZ) is known to induce hyperglycaemia and can inhibit insulin secretion in both normal subjects and patients with latent diabetes mellitus
Erle et al., Eur J Clin Pharmacol 1977
(Diabetes Mellitus) :
In three groups of normal subjects and in one group of patients with latent diabetes mellitus a study has been made of the effects of chlorpromazine (CPZ) on blood glucose and plasma insulin ... CPZ 75 mg/day for 7 days did not alter the plasma insulin response after oral glucose ; nor did CPZ 50 mg/day for 7 days affect the glucose assimilation rate or insulin response to glucose injection